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Abstract. A group of ten patients with idiopathic Parkin- 
son's disease (PD) was tested on a series of automated 
tests of learning, memory, planning and attention whilst 
either on or off L-dopa medication. Controlled with- 
drawal of L-dopa interfered with aspects of performance 
on three of the tests that had previously been shown to 
be sensitive to frontal lobe dysfunction; a spatial work- 
ing memory task, the Tower of London planning test, 
and a visual discrimination paradigm that also included 
intra- and extra-dimensional shift tests of selective atten- 
tion. More specifically, errors were increased in the spa- 
tial working memory test, and both the accuracy and 
latency of thinking were impaired. Thinking time was 
significantly slowed following L-dopa withdrawal, even 
though the possible contaminating effects on motor slow- 
ing were fully controlled by a yoked control procedure. 
Nine out of ten patients reached a further stage of the 
visual discrimination, set-shifting paradigm when on, 
rather than off, L-dopa medication. Spatial span was also 
impaired off medication, but there were no effects of 
L-dopa withdrawal on tests of pattern and spatial recog- 
nition memory, simultaneous and delayed matching to 
sample or visuospatial conditional associative l arning. 
Comparisons with a large control group confirmed 
previous findings that PD is associated with deficits on 
the majority of these tests. The results are discussed in 
terms of the fronto-striatal, dopamine dependent nature 
of some of the cognitive deficits found in PD, but the 
apparent dopamine-independent nature of deficits in 
other aspects of cognitive functioning, notably in tests of 
visual recognition memory and associative l arning. 
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L-Dopa has long been known to be efficacious in the 
treatment of the motor symptoms of idiopathic Parkin- 
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son's disease (PD) (Yahr 1990). However, it is becoming 
increasingly clear that patients with PD may also exhibit 
cognitive deficits, not only in late-in-the-course d mented 
patients (for review see Lees 1990), but even in un- 
medicated PD patients, relatively early in the course of 
the disease (Lees and Smith 1983; Sahakian et al. 1988; 
Canavan et al. 1989; Downes et al. 1989; Cooper et al. 
1991). Many of the deficits seen are reminiscent of those 
occurring after frontal lobe damage. For example, PD 
patients are impaired on the Wisconsin Card Sorting 
Test (WCST) (Lees and Smith 1983; see Brown and 
Marsden 1988, for a review), a classic index of frontal 
lobe dysfunction (Milner 1964), as well as in other forms 
of attentional set-shifting (Cools et al. 1984; Flowers and 
Robertson 1985; Downes et al. 1989). 
What is less clear is the contribution of dopaminergic 
dysfunction to hese frontal obe like deficits. This contri- 
bution could occur in several distinct ways. For example, 
the striamm is intimately associated with the frontal 
lobes via corticostriato-cortical "loops" (Alexander et al. 
1986) and damage to different sectors of the striatum can 
reproduce the effects of frontal esions (Divac et al. 1967). 
Thus, it is possible that regional dopamine depletion 
from certain sectors of the striatum could lead to frontal 
lobe type deficits. In addition, the prefrontal cortex re- 
ceives a direct mesencephalic dopaminergic nnervation 
(Bjorklund and Lindvall 1984), and depletion of frontal 
dopamine in non-human primates produces impairments 
in delayed alternation that are reversible by treatment 
with L-dopa (Brozoski et al. 1979). In PD patients, the 
effects of L-dopa on performance on tests sensitive to 
frontal lobe dysfunction have been more difficult to de- 
fine. In an early study, Bowen et aI. (1975) found that 
L-dopa improved the number of categories attained on 
the WCST, without reducing the number of perseverative 
errors. More recently, Gotham et al. (1988) found vari- 
able effects of L-dopa withdrawal in a group of PD 
patients. While verbal fluency was impaired off the drug, 
performance in two other tests, conditional associative 
learning and subject-ordered pointing appeared to show 
small improvements. Performance on the WCST was 
impaired both on and off L-dopa. From these results it 
could be concluded that L-dopa impairs, improves or has 
no effect upon cognitive function in PD. 
Recently, we have able to define a number of deficits 
in PD in tests sensitive to frontal lobe damage in man, 
including the Tower of London test of planning (Shallice 
1982; Owen et al. 1990a), a spatial working memory task 
(Owen et al. 1990a) and a test of attentional set-shifting 
(Downes et al. 1989; Owen et al. 1991). Although PD 
patients are impaired in each of these tests, the exact 
nature of the deficit differs from that seen in frontal lobe 
patients, and also depends upon the severity of the dis- 
ease. For example, PD patients are slower to think about 
their solutions on the Tower of London problems, without 
necessarily being less accurate (Morris et al. 1988; Owen 
et al. 1990b), whereas frontal patients tend to be less 
accurate, but not slower in arriving at their solutions 
(Owen et al. 1990a). Therefore, we attempted to test PD 
patients both on and off L-dopa medication in order to 
determine whether there were any consistent effects of 
L-dopa withdrawal. 
PD patients, at least later in the course, also show 
impairments in aspects of visual memory that are not 
customarily associated with frontal lobe dysfunction, 
including delayed matching to sample, a test of visual 
recognition memory that has been used to define the 
neural substrates of visual memory in non-human pri- 
mates (Mishkin 1982; Sahakian et al. t988). The latter 
study showed delay-independent impairments in PD pa- 
tients in a computerised matching to sample task which 
contrasted with the delay-dependent effects seen in pa- 
tients with Alzheimer's disease. There were also deficits 
in tests of pattern and spatial recognition memory and 
in the learning of a paired associates pattern-location 
learning task. Therefore, we tested the psychological 
specificity of the effects of L-dopa by comparing the 
effects of L-dopa withdrawal on these tests of visual 
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memory and learning with those en on the tests of 
frontal lobe function described above. 
Materials and methods 
Patients 
Ten patients with a diagnosis of idiopathic PD were studied after 
giving informed consent. All exhibited a typical bilateral akinetic- 
rigid syndrome with rest tremor. The patients had previously all 
been rated while on L-dopa according to the ttoehn and Yahr (1967) 
scale of clinical disability. Six of the patients were rated III, three 
were rated IV and one was given the most severe rating of disability, 
V. None of the patients showed clinical signs of depression, demen- 
tia, psychosis or focal cortical pathology. All of the subjects had 
been maintained onL-dopa preparations (Madopar and Sinemet) 
in combination with a peripheral decarboxylase inhibitor and had 
shown a considerable clinical response. The relevant patient data 
are presented in Table 1. 
Large control samples 
The main purpose of this study was to test the effects of L-dopa on 
cognitive function in PD patients on tasks already known to be 
Table 1. Patient data (mean ± SEM) 
Age 58.7 ± 4.9 years 
Sex 2 females, 8 males 
Length of education 9.8 ± 0.4 years 
Age at onset of disease 48.9 ± 5.3 years 
Duration of disease 9.6± 1.6 years 
Dosage of L-dopa 1130 4- 131 tug,day 
Duration of L-dopa therapy 8.3 + 1.2 years 
Wechsler Adult Intelligence Scale t 13.2i 3.6 
(verbal) 
National Adult Reading Test 115.6 ± 2.6 
Kendrick Object Learning Test 31.0+ 2.2 
Table 2. Means and standard errors for normal control sample 
Working memory and planning battery (N = 55) Visual memory battery (N = 46) 
Age 55.6 (0.6) 
NART 116.5 (1.0) 
Spatial span 5.3 (0.1) 
Spatial working memory (between search errors) 
4 boxes 2.1 (0.4) 
6 boxes 10.1 (1.1) 
8 boxes 27.4 (1.7) 
Tower of London test 
Number of perfect solutions 8.2 (0.2) 
Initial thinking 
time (s) 
Age 56.7 (0.5) 
NART 117.5 (t.1) 
Pattern recognition 20.9 (0.36) 
Spatial recognition 16.4 (0.31) 
Matching to sample (% correct) 
Simultaneous 98 (2.0) 
Delay 0 s 98 (1.4) 
4 s 91 (3.4) 
8 s 84 (4.0) 
16 s 88 (3.7) 
0 s (retest) 94 (3.3) 
Subsequent thinking time Paired associates 
(s per move) learning 
2 moves t.57 (0.16) 0.31 (0.08) 
3 moves 8.11 (0.85) 0.54 (0.10) 
4 moves 8.90 (0.66) 3.23 (0.45) 
5 moves 11.30 (0.93) 2.03 (0.23) 
Total trials to 13.3 (0.4) 
criterion 
Total errors to 7.7 (1.06) 
criterion 
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sensitive to deficits in PD. However, for the purpose of comparison, 
control data for the main dependent variables have been provided 
from the standardized scores of large groups of healthy normal 
control subjects and are shown in Table 2. The control subjects were 
drawn from a large population of volunteers aged between 50 and 
59 years from London, Cambridgeshire and Newcastle-upon-Tyne 
(North-East Age Research Panel). These controls had no history of 
neurological or psychiatric disorder. 
Procedure 
There were two testing sessions eparated by a minimum of 4 and 
a maximum of 8 days. The order of testing on or off L-dopa was 
counterbalanced across the group; five patients were tested first on 
L-dopa and five off L-dopa, thus averaging possible practice ffect 
across treatments. For the neuropsychological testing off L-dopa, 
the patients had ceased all antiparkinsonian medication for a mini- 
mum of 13 h prior to testing. The motor disability of each subject 
was assessed both on and off L-dopa using the King's College 
Hospital Parkinson's Disease Rating Scale. This evaluates 39 symp- 
toms and signs each on a 0 to 3 scale with a maximum disability 
score of 117. 
sequence. After each successful trial, the number of boxes changing 
in the next sequence was increased by one to a maximum of nine 
boxes. After an incorrect attempt at any particular level, an alter- 
native sequence of the same length was presented. This continued 
until the subject had failed three consecutive trials at any one level. 
During each trial, a number in the bottom left hand corner of the 
screen indicated the length of the current sequence. Also, all boxes 
changed to the same colour within each series, although on any two 
adjacent sequences different colours were used to minimize inter- 
ference. The spatial short term memory span was calculated as the 
highest level at which the subject had successfully recalled at least 
one sequence of boxes. 
The following three tests are all sensitive to frontal obe damage 
(Owen et al. 1990a, 1991). 
Spatial Working Memory Task. In this task the subject was required 
to "search through" a number of coloured 3 cm boxes presented on 
the screen, by touching each one in order to "open it", thus reveal- 
ing its contents (see Fig. tA). The colours of the boxes stayed 
constant within a trial, but varied over trials. The goal was to collect 
blue "tokens" hidden inside the boxes, and once found, to use them 
to fill an empty column at the side of the screen. The subjects were 
instructed that at any one time there would be a single token hidden 
Clinical neuropsychological ssessment 
Prior to the experiment, all patients received the National Adult 
Reading Test (NART) (Nelson 1982) to obtain an estimate of their 
optimal intellectual ability. Verbal IQ was prorated from two sub- 
tests of the Wechsler Adult Intelligence Scale (WAIS), Vocabulary 
and Similarities. The Kendrick Object Learning Test was also ad- 
ministered as a screen for possible dementia (Kendrick 1985). 
Experimental computerized tests 
The main testing procedures were taken from the Cambridge Neu- 
ropsychological Test Automated Battery (CANTAB), a series of 
computerized tests run on an Acorn BBC Master 128 Microcom- 
puter, with a high resolution Microvitec 12 inch VDU and a Mi- 
crovitec Touchtec 501 touch-sensitive screen. These were generally 
administered in one test session lasting for about 100 min. Subjects 
were seated approximately 0.5m from the monitor and it was 
explained that they would have to respond to stimuli by touching 
the screen. 
They were introduced to the apparatus by way of a "sen- 
sorimotor screening task" in which they were asked to respond to 
a series of flashing crosses on the screen by placing the index finger 
of their preferred hand onthe centre point of each cross. All subjects 
satisfactorily completed this task and so were allowed to proceed 
to the following experinaental tests. The first three tests were then 
taken from the CANTAB Working Memory and Planning battery 
(see Owen et al. 1990a). 
Spatial short term span. In this computerized version of the Corsi 
Block Tapping task, the ability of subjects to remember a sequence 
of squares highlighted on the screen was determined. Each trial 
began with the same arrangement of nine white 3 cm squares ar- 
ranged quasi-randomly in the space of the screen. Subjects were 
instructed to observe the boxes, as some would change colour one 
after the other. Their task was to remember the location and the 
sequential order of the boxes changing colour. During each series, 
one box would change colour for 3 s and then return to white before 
the next in the sequence changed to the same colour. The subject 
was then prompted by a tone to repeat he sequence by touching 
the boxes in the same order. During this response sequence, each 
selected box changed to the same colour for one sec and a feedback 
tone sounded. Following one demonstration trial by the experiment- 
er, the task began at the simplest level of difficulty with a two box 
D 
A 
C 
Fig. 1. A The arrangement of boxes on the screen for the spatial 
working memory task. The example shows a 6 box trial, in which 
one of the boxes has just been chosen toreveal a "blue token" which 
can now be added to three already in the column on the right hand 
side of the scren. This leaves the subject with 2 more tokens to find, 
in boxes in which they have not previously been located. B A sample 
3 move problem for the modified Tower of London task. The goal 
position of the balls is shown in the top arrangement. C Sample 
pairs of compound stimuli and their arrangement on the screen in 
the ID/ED attentional set shifting task 
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inside one of the boxes. Their task was to search until they found 
it, at which point the next token would be hidden. The key instruc- 
tion was that, once a blue token had been found within a particular 
box, then that box would not be used again to hide a token for that 
particular trial. Since every box was used once, on each trial the 
total number of blue tokens to be found corresponded to the 
number of boxes on the screen. In this task, two types of search 
error are possible. First, a subject may return to open a box in which 
a blue counter has already been found (a "between search" error). 
Second, a subject may return to a box already opened in the same 
search sequence (a "within search error"). Subjects could search the 
boxes in any order, but for control purposes, the number of boxes 
visited (excluding errors), before a token was found was determined 
by the computer. Thus, each subject received the same degree of 
feedback prior to the first error. After two practice trials with three 
boxes, there were four test trials with each of four, six and finally, 
eight boxes. The task was scored according to the number of be- 
tween and within search errors at each level of difficulty, but the 
number of within search errors was sufficiently small to preclude 
analysis. 
Planning task. This task is closely related to one developed by 
Shallice and McCarthy, the "Tower of London", that provides 
simpler versions of the "Tower of Hanoi" problem (Shallice 1982). 
Two sets of three coloured balls were presented, one in the top half 
of the screen and one in the bottom half. These were described to 
the subject as snooker balls since they appeared to be hanging in 
"pockets" or "socks" (see Fig. 1B). There were three pockets in each 
half of the screen, one that could clearly hold three balls, one that 
could hold two balls, and one that would be completely filled by one 
ball. On each trial a red ball, a blue ball, and a green ball were placed 
in predetermined positions in the pockets of each of the two dis- 
plays. The subject was asked to rearrange the balls in the bottom 
display, such that their positions matched the "goat" arrangement 
in the top half of the screen. A ball could be moved by the subject 
first touching it and then touching an empty position in e of the 
other pockets. Once selected, a tone sounded and the rim of the ball 
began to flash, indicating that it was ready to be moved. At any 
time, the subject could cancel a selected ball by touching it a second 
time. "Illegal" moves, such as trying to remove a ball while there 
was another sitting above it in the same pocket, were carefully 
explained to the subject and, if attempted, they were registered, but 
evoked no response from the computer. 
The starting position of the balls was varied such that in any 
particular trial the solution could only be reached after a minimum 
of two, three, four or five moves. Subjects were instructed to exam- 
ine the position of the balls at the beginning of each problem and 
attempt to solve it in the minimum possible number of moves. This 
was both given to them verbally and displayed on the screen 
throughout each trial. They were encouraged not to make the first 
move until they were confident hat they could execute the entire 
sequence needed to solve the problem. The maximum moves allow- 
ed corresponded to twice the minimum number possible plus one, 
or plus two, in the case of five move problems. Following the 
successful completion of each problem, the VDU displayed the 
word "FINISHED",  before moving on to the next trial. The pro- 
gram stored the number of moves required by the subject to re- 
arrange the balls and measured the selection and movement laten- 
cies for both the first and the subsequent moves. After six practice 
problems with one and two moves, the subject was given two each 
of two and three move problems and four each of four and five 
move problems. These test problems corresponded exactly to those 
used in the original Tower of London test. 
For each test problem a "yoked control" condition was em- 
ployed to provide baseline measures of motor initiation and execu- 
tion times. On each trial of this control condition, the subject was 
required to follow a sequence of single moves executed by the 
computer in the top half of the screen by moving the corresponding 
ball in the lower arrangement. Thus, initially the two arrangements 
differed by just one ball. Once the subject had made the appropriate 
move, the top arrangement changed again, so that the subject had 
to make another single move. The test was "yoked" to the main test 
in the sense that in each trial, the movement of the balls was an exact 
replication of those moved by the subject in the corresponding test 
trial. The measurement of selection and execution latencies in this 
control condition provided baseline estimates of motor initiation 
and execution times. 
Test trials and "yoked" control trials were arranged in four 
blocks of six problems each. The first six test trials were give1 (two 
problems at each of two, three and four moves), followed by their 
corresponding "yoked" control trials. Then the remaining six test 
problems were presented (two at four moves and four at five 
moves), followed by their yoked control trials. Between each block 
change there were two practice trials to ensure that the requirements 
of the current set of tasks had been fully understood. 
Accuracy of performance. Across the 12 test problems the main 
measure was the proportion of problems olved in the minimum 
number of moves specified ("perfect solutions"). 
Latency measures of performance. Baseline measures of motor 
initiation and motor execution times were extracted from the 12 
"yoked control" trials. In all cases, latencies were recorded in cen- 
tiseconds and converted to seconds for the purpose of presentation. 
The motor initiation time was the mean time between the onset of 
each problem, and the initiation of the first move (i.e. a correct 
touch of the required ball). The motor execution time was the time 
between touching the first ball and completing the sequence of
single moves that comprise the whole problem. Since these control 
problems were yoked to the test problems, the total execution time 
was divided by the number of moves to provide an estimate of the 
average movement time per move. The motor initiation and execu- 
tion times were used to derive estimates of planning or "thinking" 
time in the main task. Two separate stimates were calculated. In 
each problem, the initial thinking time was the time between the 
presentation of the problem and the first touch, minus the corres- 
ponding motor initiation time, as calculated from the 'yoked con- 
trol' task. The subsequent thinking time was the time between the 
selection of the first ball and the completion of the problem minus 
the total motor execution time from the corresponding control 
problem. Since this measure clearly varied with problem length, 
subsequent thinking time scores were divided by the number of 
moves to give an estimate of the average thinking time "per move". 
In this way, pure estimates of initial and subsequent thinking times 
were derived, unconfounded by motor initiation or execution times. 
Visual discrimination paradigm; attentional set-shifting. The next 
test to be administered was taken from the CANTAB Attentional 
test battery. 
The test set-up and stimuli were shown to the subjects. Four 
rectangular boxes, to the top and bottom and to. the right and left 
of centre, appeared on the screen. Two of these contained the test 
stimuli but the boxes used changed from trial to trial Subjects were 
instructed in the following way: 
Now you can see two patterns. One of the patterns is correct. You 
must point to the one you think is correct. There is a rule you can 
follow to make sure you make the correct choice each time. The 
computer will be keeping track of how well you are doing and when 
it is clear that you know the rule the computer will change it, but 
this will not happen very often. To begin with, there is nothing on 
the screen to tell you which of the two patterns is correct, so your 
first choice will be a simple guess. However, the computer will give 
a message after each attempt o tell you whether you are right or 
wrong. You can start now. 
The test then proceeded through a number of stages, each with 
a different contingency, up to a maximum of nine (see Fig. 1C). For 
each, continuation to the next stage was dependent on a criterion 
of six successive correct discriminations being reached. If criterion 
was not reached by the 50th trial of a stage, then the test was 
discominued and subjects did not proceed to the following stage. 
The order of discrimination was fixed, so that the EDS always 
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followed the IDS. However, previous work has established that 
comparable effects are found when the alternative ordering is used 
(Roberts et at. 1988). More detailed rationales for the exact design 
of the test can be found in previously published articles (Downes 
et at. 1989; Roberts et al. 1988). 
To begin with, subjects were given a simple simultaneous dis- 
crimination in which the stimuli varied along only one of the two 
"dimensions" for deriving the stimuli. These dimensions were pur- 
ple-filled shapes or white lines. The starting dimension was balanced 
across subjects and groups. A response to one of the two boxes 
containing the stimuli resulted in an auditory tone, together with 
visual feedback which informed the subjects of the correctness of 
their responses. This feedback was in the form of the words "cor- 
rect" and "wrong" presented, respectively, in green and red lettering 
above the middle two boxes. The same feedback was used for each 
of the subsequent s ages. After 1.5 s the screen cleared and an 
intertrial interval of 1 s was begun. 
Following the initial simple discrimination (SD), the remaining 
eight stages were as follows. For the second stage (SDR), the 
discriminanda remained the same, but the previously incorrect 
choice became the correct one and vice versa, that is the contingen- 
cies were reversed. At the third stage (C-D) the second imension 
was introduced with one exemplar of each dimension paired togeth- 
er to form a compound stimulus in two of the response boxes. To 
succeed, a subject had to continue to respond to the correct exem- 
plar of the previous stage. For this and all subsequent stages, 
exemplars of the different dimensions were paired in a pseudoran- 
dom fashion so that all four possible compound stimuli were used, 
with the constraint that runs of no more than three trials with the 
same pairings were allowed. The stimuli for the fourth stage (CD) 
and subsequent stages were also compounds, but the two exemplars 
from the different dimensions were superimposed, with the white 
line always in the foreground. The contingencies were again un- 
changed from those for the previous two stages. A reversal then 
occurred at the fifth stage (CDR). New exemplars for both dimen- 
sions were introduced at the sixth stage, the intra-dimensional shift 
(IDS), but the relevant dimension (i.e. shapes or lines) was un- 
changed from stage 1. This was followed by a further eversal at the 
seventh stage (IDR). For the penultimate stage, the extra-dimen- 
sional shift (EDS), new exemplars were again introduced, but suc- 
cess at this point depended on the subject shifting response set to 
the exemplars of the previously irrelevant dimension. Finally, con- 
tingencies were reversed to the previously incorrect exemplar of the 
new dimension (EDR). The main measure of performance on this 
task was the stage successfully attained. 
Tests of visual memory and learning. In the last part of the test 
session, all patients received computerized tests of visual memory 
and learning identical to those previously described in detail (Saha- 
kian et al. 1988). These included tests of pattern and spatial recog- 
nition, simultaneous and delayed matching to sample, and a con- 
ditional visuospatial ssociative l arning task. In the pattern recog- 
nition task, a number of abstract visual stimuli are displayed one 
by one in the centre of the screen before recognition memory is 
tested in a two-alternative forced choice task, where the original 
stimulus is presented with a novel one and the subject has to pick 
the former. The test consists of two "lists" of 12 stimuli each, 
comprising 24 in all. In the spatial recognition task, open white 
squares are presented ina number of spatial locations on the screen, 
before recognition memory for location is tested, again with a 
two-alternative forced choice procedure. There were 4 blocks of 5 
stimuli each, comprising 20 in all. In the matching to sample test, 
the first phase (perceptual m tching) consists of the simultaneous 
presentation f a complex abstract stimulus, varying in both colour 
and shape, with four matching stimuli. Subjects are required to 
choose the matching stimulus in a four-alternative forced choice 
procedure. In the second phase (memory matching), the matching 
stimuli are presented in five trial blocks following a delay of 0, 4, 
8 or 16 s, followed finally by a retest at 0 s. This delayed matching 
to sample test thus assesses the forgetting of the stimuli to be 
recognised after a short delay~ 
The conditional visuospatial paired associates test is identical to 
one described as the delayed response task in Sahakian et al. (1988). 
Here, however, the emphasis was on the learning as distinct from 
mnemonic aspects of the task. Abstract visual stimuli were present- 
ed one by one in a ring of six (and in the last stage, eight) "boxes" 
arranged around the screen. The stimuli were then re-presented one 
by one in the centre of the screen and the subject indicated in which 
box they had been previously presented. Subjects were given up to 
ten trials to learn the location of each stimulus of the set, before 
proceeding to the next stage. Failure to reach criterion at any stage 
resulted in the premature termination of the test. The test began 
with only one stimulus location to be remembered and then gradu- 
ally increased to 2, 3, 6 and 8 stimuli. 
Statistics 
The main hypothesis to be tested was the effects of ~-dopa on 
performance in the PD group and this was generally assessed in a 
within-subjects design using analysis of variance (Winer 1971) with 
one or two factors depending on the task. 
Results 
Effects of L-dopa on motor disability score 
As expected, L-dopa withdrawal  led to considerable 
worsening of  ratings o f  motor  disabi l i ty (mean scores, on 
L-dopa t6.8~:2.0;  off L -dopa 63.9+4.4) .  
Comparison of cognitive performance of PD patients 
and controls 
Table 2 summarizes mean (+ SD) scores for most  of  the 
dependent  variables used in the cognit ive test battery for 
large groups o f  healthy contro l  subjects o f  similar age 
and verbal  IQ to the PD group used in this study. Com- 
par isons of  these values with those shown by the present 
PD patients conf i rm the results of  earl ier studies (Saha- 
kian et al. 1988; Morr is  et al. 1988; Owen et al. 1990b) 
showing substant ia l  deficits in the medicated PD group 
in each of  the tests of  visual memory  (pattern and spatial  
recognit ion, delayed matching to sample) or learning 
(condit ional  v isuospatial  associative l arning) and two of  
the tests sensitive to frontal  lobe dysfunct ion (the Tower 
of  London (for init ial th inking time only) and attent ional  
set-shifting). In the cases of  spatial  work ing memory  and 
spatial  span, there were no significant deficits in this 
group of  PD pat ients on L-dopa medicat ion,  again con- 
sistent with previous findings (Morr is  et al. 1988). 
Effects of L-dopa medication  tests sensitive to j?ontal 
lobe dysfunction 
Tower of London planning task; thinking latency and 
accuracy. Figure 2 shows the per formance o f  the PD 
group on and off L-dopa medicat ion for measures of  the 
accuracy and latency of  thinking in the Tower of  London 
planning task. In general, patients per formed significant- 
ly better on L-dopa for both the accuracy and latency 
variables. As expected, initial th inking time (Fig. 2A) was 
longer as a funct ion o f  prob lem difficulty (F= 11.90, 
df= 3,27; P < 0.001). There was a significant lengthening 
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df  = 3,27; P< 0.05). The initial thinking time shown in 
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previous studies (Morris et al. 1988; Owen et al. 1990b), 
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60 ¸ 
400 
A 80,  
20 
"5 
0 
0 
40  
c 
n 
C 35 
Pattern 
TEST 
Spatial  
0 
,O 
B~OO 
90'  
80 ¸  
70 -  
,~ 60 
g= 
50 
12. 
40-  
30 
20 i i i i i J 
S M 0 sec 4 sec 8 sec 16 sec 0 sec (retest) 
Delay 
..D 
E 
Z 
1.- 
3O 
25 
20 
15 
10 
Measure 
Tr ia ls  E r rors  
Fig. 5A-C. Lack of effect of L-dopa withdrawal onpertbrmance ofthree 
tests of visual memory and learning: A Pattern and spatial recognition 
memory (n) On L-dopa; (N) off L-dopa; B matching to sample perfor- 
mance (both simultaneous and delay components) (-D--) On L-dopa; (- I -)  
off L-dopa; C conditional visuospatial associative learning (I) On L-dopa; 
(EN) off L-dopa. Shown on the left is mean cumulative trials to reach 
criterion up to and including the s t of 8 stimuli. Shown on the right is the 
mean number of cumulative errors committed in attaining criterion up to 
and including the setof 6 stimuli. The vertical bars indicate SEM values 
5 move) problems. Following L-dopa withdrawal, the 
initial thinking time increased substantially to over 35 s. 
Compared with normal controls (Table 2) prolonged 
subsequent thinking times in the PD patients were not 
evident when patients were on L-dopa (mean scores, 0.26, 
1.03, 2.12 and 1.92 s per move at 2, 3, 4 and 5 move 
problems, respectively). However, withdrawal of L-dopa 
significantly lengthened this index of thinking latency 
(F=5.15, df= 1,9; P<0.05), the respective mean dura- 
tions at each level of problem difficult), being 0.51, 1.10, 
3.00 and 2.78 s per move. There was also a main effect 
of difficulty (F= 9.66; df= 3,27; P < 0.01), but no interac- 
tion with L-dopa medication (F< 1.0). 
Thinking accuracy, as measured by the most sensitive 
index, perfect solutions (i.e. those solved in the minimum 
number of moves), also showed an impairment when 
tested off L-dopa medication (Fig. 2B), but only for the 
4 and 5 move problems (F=15.3, df=l ,9 ,  P<0.01). 
However, performance of the PD group on medication 
was comparable to that of the large control sample 
(Table 2), averaging about 8/12 problems olved in the 
minimum number of moves in both cases. 
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Tower of London; yoked motor control measures. On the 
yoked motor control test, the PD patients were unaffect- 
ed by L-dopa withdrawal either for the initial or the 
subsequent movement time measures (both F< 1.0, NS). 
The mean values for the initial movement time were 
2.14 s (off L-dopa) and 2.25 s (on L-dopa). For subse- 
quent movement time, the equivalent values were 3.2 s 
and 2.8 s. 
Visual discrimination paradigm; attentional set-shifting. 
Figure 3 shows the proportion of PD patients reaching 
criterion at each stage of the discrimination learning 
paradigm. The performance of the patients on L-dopa 
was strikingly similar to that of the medicated PD pa- 
tients described by Downes et al. (1989). For com- 
parison, the performance of a group of 129 healthy con- 
trols is shown, confirming the deficit shown previously in 
PD (Downes et al. 1989). Only 50% of the patients on 
L-dopa successfully completed all stages of the task, 
compared to the control rate of about 74%. Most of the 
failure was at the attentional set-shifting stage (i.e. the 
extradimensional shift), where 38% of those PD patients 
attempting this stage failed, compared to the control 
value of 17%. As shown in Fig. 3 performance offL-dopa 
medication was significantly worse than on the drug. 
Nine out of ten PD patients reached a further stage of 
the test on L-dopa (binomial test, P = 0.022, two-tailed). 
Spatial working memory. Figure 4 shows the ffects of 
L-dopa on between search errors, the main index of 
performance on the spatial working memory task. There 
was a significant Difficulty X Medication interaction 
(F= 18.03, df=4,36; P<0.001), with performance on 
L-dopa being superior at the six and eight box levels. 
Effects of L-dopa medication spatial span and visual 
memory 
The PD patients had a span of 4.4(+ 0.3) on L-dopa nd 
3.2( __ 0.2) off the drug, a significant difference (F= 17.05, 
df= 1,9; P < 0.001). Normal controls average 5.3 (Table 2). 
Figure 5A shows that spatial and pattern recognition 
performance were not at all affected by L-dopa medica- 
tion (both F< 1.0, ns), although the overall performance 
of the PD patients was markedly deficient compared with 
the control sample (Table 2). 
Figure 5B shows that L-dopa had no beneficial effect 
on matching to sample performance, ither for the simul- 
taneous or the delayed versions (F=1.33, df= 3,27; NS), 
although comparison with the data of Table 2 shows the 
delay-independent deficit in matching to sample perfor- 
mance originally described by Sahakian et al. (1988). 
Latency measures on the matching to sample task 
were unaffected by L-dopa medication. For simultaneous 
matching to sample the PD patients averaged 5.2 s on 
L-dopa and 4.7 s off the drug (F< 1.0, ns). For delayed 
matching to sample the latencies on the drug varied from 
4.3 s (0 s delay) to 4.98 s (4 s), whereas off L-dopa the 
scores were slightly, but not significantly (F=2.03, 
df= 1,9), increased to 4.44 s (0 s delay) to a maximum 
score of 6.02 s (16 s). 
Conditional visuospatial associative learning. Whereas 
healthy subjects hardly ever fail this task (Sahakian et al. 
1988), seven out of ten PD patients uccessfully reached 
the criterion of learning at the most difficult level (eight 
boxes) on this task when on L-dopa, while 6/t0 patients 
were successful off the drug. Using a more sensitive trials 
to criterion index, Fig. 5C shows that L-dopa had no 
substantial effects on the trials to criterion measure of 
this learning test (F< 1.0, ns) even though the PD pa- 
tients were performing at a markedly inferior level to that 
of healthy controls (Table 2), in confirmation of earlier 
findings (Sahakian et al. 1988). Also shown on Fig. 5C 
is the lack of effect of L-dopa on errors to criterion, only 
including the data for six boxes, which all patients 
attempted, both on and off J.-dopa; again there were no 
significant effects of medication (F< 1.0, ns). 
Discussion 
The main results found in this study were that L-dopa 
withdrawal selectively impaired performance on some of 
the tests of cognitive function, notably those previously 
shown to be sensitive to frontal lobe damage, without 
affecting performance on other tests of visual memory 
and learning. These results suggest that the effects of 
L-dopa are psychologically specific in some sense and 
argue that some, but not all, of the parkinsonian cog- 
nitive impairment isdue to a loss of central dopaminergic 
function. 
The PD patients were impaired in all three of the tests 
previously shown to be sensitive to frontal lobe dysfunc- 
tion. On the Tower of London test, the initial thinking 
time was slower than normal, as previously documented 
(e.g. Morris et al. 1988; Owen et al. 1990b). However, 
L-dopa withdrawal dramatically exacerbated this deficit 
and led to average thinking times of about 36 s on the 
most difficult (five move) problems. Two other measures 
on this test also showed large effects of L-dopa treatment, 
although these aspects of the test are not generally im- 
paired in patients on medication. Subsequent thinking 
time (i.e. the time taken to think about the problems 
subsequent to the first move) was also lengthened in the 
absence of L-dopa, and the number of perfect solutions 
of the problems, an index of thinking accuracy, also 
declined under these conditions. These latter results are 
of particular interest as they suggest that L-dopa therapy 
may normally be masking underlying deficits, which be- 
come apparent upon its withdrawal. A similar conclusion 
holds for the test of spatial working memory, where the 
PD patients exhibited no deficits in terms of the number 
of between search errors (as in previous studies, e.g. 
Morris et at. 1988) but L-dopa withdrawal led to substan- 
tial impairment. These findings may also help to explain 
why there is an apparent progressive impairment on 
some of these tests in PD patients. Thus, it has recently 
been found that PD patients with severe clinical disability 
can show increased numbers of errors on the spatial 
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working memory test, as well as impaired thinking ac- 
curacy on the Tower of London test, even when on 
medication (Owen et al. 1990b). It is possible for these 
patients either that L-dopa is losing some of its efficacy 
in counteracting the cognitive impairments or that its 
effects are being undermined by the progressive loss of 
central dopamine in frontostriatal regions. 
Probably the most sensitive of the three frontal tests 
to PD is the attentional set-shifting task, particularly in 
its extradimensional shift phase. A previous study has 
found that unmedicated, early-in-the-course PD patients 
are impaired in this task (Downes et al. 1989), whereas 
their performance on the Tower of London and the 
spatial working memory task is essentially normal (Owen 
et al. 1990b). It is noteworthy that the former study 
found that, if anything, the unmedicated PD patients 
were more  severely impaired than the later-in-the course 
medicated PD patients (who are generally more cog- 
nitively impaired on other tests, see Sahakian et al. 1988). 
This suggests that the L-dopa medication may have been 
promoting effective attentional shifting in these patients, 
thus boosting their performance even above that of the 
unmedicated, mildly affected patients. Some evidence for 
this possibility was obtained in the present study. Nine 
out of ten of the PD patients reached a later stage in the 
discrimination learning paradigm when under L-dopa 
medication. These data support he possibility that striat- 
al or frontal dopamine may influence attentional set. 
However, the PD patients were so impaired on this test 
when off medication, that very few of them actually 
reached the stage of extradimensional shifting and thus 
it was difficult to test the specific hypothesis that dopa- 
mine is particularly important for attentional shifting 
per se. 
The results for the discrimination learning paradigm 
are in ageement with t ose of Bowen et al. (1985), who 
found that patients under L-dopa achieved more catego- 
ries on the WCST. They are less consistent with those f 
Gotham et al. (1988) or an unpublished study by Goth- 
am, Brown and Marsden showing no detrimental effect 
of L-dopa withdrawal on WCST performance. The rea- 
sons for this discrepancy may arise from subtle task- 
related factors. For example, the WCST is a more com- 
plex test than the attentional set-shifting paradigm and 
the PD patients may fail it for reasons unrelated to their 
failure on the discrimination learning paradigm. It is also 
possible that the effects of L-dopa withdrawal in Parkin- 
son's disease vary according to the stage of the disease. 
As can be seen from the Hoehn and Yahr ratings of 
clinical disability, the present PD patients were quite 
severely affected, and so were presumably quite late in 
the course of the disease. It is possible that L-dopa med- 
ication is disruptive rather than beneficial to cognition in 
patients earlier in the course of the disease and this 
possibility requires further evaluation. 
In general, the results we have found are apparently 
consistent with ose of Gotham et al. (1988) for verbal 
fluency, another commonly used frontal lobe test. How- 
ever, they do not lend support to the hypothesis that 
frontal lobe type deficits arise from L-dopa medication, 
as suggested from the results of that study. This hypoth- 
esis suggests ingeniously that the caudate nucleus is 
"overdosed" with L-dopa medication as a result of the 
optimal treatment of the motor deficits that arise from 
the more severe loss of dopamine in the putamen. The 
main data in support of this position are the results of 
two tests, conditional associative learning and subject 
ordered pointing, which are both suggested to be sen- 
sitive to frontal lobe damage on the basis of other work 
(see Milner 1982). However, in relation to the present 
results, the following points can be made. First, although 
the test of conditional associative l arning used in the 
study by Gotham et al. (1988) is sensitive to the effects 
of frontal lobe damage (Canavan et al. 1989), its strong 
learning and memory components may also make it 
susceptible to other forms of CNS damage, for example 
in the right hippocampus (Petrides 1985). Second, a test 
of conditional associative l arning was also used in the 
present study, but L-dopa withdrawal had no effect (see 
below). Third, close examination of the Gotham et al. 
results suggests in fact that there is no discrepancy with 
the present results. When a direct comparison was made 
between the effects of the presence and absence of L- 
dopa, no significant effects in either conditional learning 
or subject ordered pointing were present. The apparent 
deficit in the L-dopa treated condition arose in com- 
parison with an untreated control group. 
The present results could conceivably arise from some 
form of artifact produced by L-dopa withdrawal, but we 
think that this is unlikely. First, it.coutd be argued that 
the effects are secondary to the imposition of severe 
parkinsonian motor symptoms, which may have the ef- 
fect of distracting the patient from task requirments or 
more directly affecting his or her responding to he touch 
sensitive screen. It is certainly the case that the clinical 
measures of motor function revealed a significant effect 
of L-dopa withdrawal. However, it is unlikely that they 
contributed materially to the observed cognitive deficits 
for the following reasons. First, on the Tower of London, 
any motor effect of the disease was taken into account 
when correcting for thinking times. Thus, patients were 
required to make moves in a yoked situation which 
required no planning and these scores were used to adjust 
the actual thinking times. Second, and perhaps more 
importantly, there were no significant effects of L-dopa 
removal on the latency to respond, either in the yoked 
control task for the Tower of London, or on other mea- 
sures of latency, for example, on the matching to sample 
task. Another possible explanation of the impairment 
produced by L-dopa withdrawal is an indirect result of 
depressed mood and arousal (Brown et al. 1984). How- 
ever, in a later study, Gofham et al. (1988) found no 
relationship between changes in mood and arousal and 
task performance. In this study, we argue against this 
explanation because the pattern of cognitive improve- 
ment under L-dopa was specific. Thus, visual memory 
and learning were not impaired on L-dopa withdrawal, 
and there seem to be no obvious ways in which these 
tasks would benefit differentially from elevations in 
mood or arousal. Indeed, a recent study has shown that 
the visual memory and learning tests used here are sen- 
sitive to deficits in elderly depressed individuals (Abas et 
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al. 1990). It is also worth noting that the motor requir- 
ment of, for example, the attentionat set shifting task, is 
not substantially different from that of the delayed 
matching to sample procedure. 
The PD patients tested here, while not demented, were 
quite seriously impaired in all of the tests of visual mem- 
ory and learning, thus supporting previous work (Saha- 
kian et al. 1988;,E1-Alwar et al. 19.87; Brown and Mars- 
den 1988 for a review). Quite surprisingly, these d ficits 
were not at all responsive to L-dopa withdrawal. This can 
hardly be due to differences in task sensitivity, as the tests 
of visual memory and learning are more sensitive to early 
in the course Alzheimer disease than the attentional set- 
shifting task (Sahakian et al. 1990). Nor is it because of 
any lack of consistency in these measures or patient 
selection, as other authors have found exactly the same 
result for these same memory tests in a different group 
of PD patients (Gotham, Brown and Marsden u pub- 
lished results). Thus, these impairments in memory func- 
tion may be mediated by non-dopaminergic mechanisms, 
perhaps consistent with the wealth of evidence that PD 
patients may have deficits in the functioning of the cholin- 
ergic, noradrenergic and serotoninergic innervations of 
the cortex and the hippocampus (Agid et al. 1987). It is 
perhaps urprising that g-dopa did not modulate memory 
function in view of the suggestion that dopamine contrib- 
utes to the "effortful" processes of free recall that are 
often deficient in patients with PD and depression (Wein- 
gartner et al. 1984). However, this may not apply to the 
present ests, which mainly employed tests of memory 
function based on recognition rather than recall. 
The only result which does not support our strong 
argument of a selective ffect on frontal lobe type func- 
tions is on the test of spatial span, which did show large 
effects of L-dopa removal, but is not very sensitive to the 
effects of frontal lobe damage (Owen et al. 1990a). One 
possible explanation for this is that the Corsi span task 
might be sensitive to the effects of damage of other 
cortical regions, for example, the right parietal cortex, 
which has recently been shown to among those more 
posterior cortical regions that receive a substantial dopa- 
minergic innervation in the primate brain (Berger et al. 
1991). 
Overall, we believe that we have demonstrated pro- 
found deficits in tests sensitive to frontal obe damage in 
PD patients experiencing L-dopa withdrawal, while 
producing no exacerbation of memory and paired asso- 
ciates learning deficits. Future studies will aim to define 
those regions of  the frontostriatal system responsible for 
these dopamine dependent effects on cognition and to 
extend the results to include longitudinal studies of  PD 
patients beginning to receive medication. Finally, we 
hope to be able to pursue the possibility of doubly 
dissociable ffects on cognitive function in PD, depen- 
dent upon deficiencies in different neurotransmitter sys- 
tems. 
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